Biotech and Pharmaceuticals
U.S. monkeypox outbreak is slowing as vaccines become more accessible, health officials say
The U.S. monkeypox outbreak is slowing as vaccines have become more available and there’s broader public awareness about what actions individuals can take to lower their risk of infection, according to White House health officials. Demetre Daskalakis, deputy head of the White House monkeypox response team, said it took 25 days for cases to double […]
Read More
Omicron boosters are a key milestone, but aren’t likely to woo new investors to Pfizer, Moderna
It’s a new milestone in the Covid-19 pandemic. People will soon roll up their sleeves and get jabbed with a booster shot tailored to the dominant coronavirus strain circulating in the U.S. Health officials have suggested this is likely to become a new pattern, joining the annual ritual of the flu shot. “For the first […]
Read More
New York ends mask requirement for subways, buses and other mass transit
A Metropolitan Transportation Authority (MTA) logo is displayed on the side of a subway train in Manhattan, New York on June 2, 2021. Ed Jones | AFP | Getty Images New Yorkers are no longer required to wear masks on mass transit, Gov. Kathy Hochul announced on Wednesday. Hochul said the decision to lift the […]
Read More
People who recently caught Covid can wait a few months to get omicron booster, top health official says
People walk by a Covid-19 testing site at Times Square on May 12, 2022 in New York City. Liao Pan | China News Service | Getty Images People who recently caught Covid can wait a few months to get a new omicron booster, White House Covid response coordinator Dr. Ashish Jha said on Tuesday. Studies […]
Read More
Omicron boosters should provide better protection against infection and serious illness, U.S. health officials say
U.S. health officials expect new omicron boosters will provide better protection against infection and serious illness this fall because the new shots now match the dominant coronavirus variant. The new omicron shots mark a milestone in the pandemic that will help the U.S. more effectively fight the virus, White House Covid response coordinator Dr. Ashish […]
Read More
New omicron boosters are now available, but it’s unclear how effective they will be
The U.S. authorized the first major makeover of the Covid-19 vaccines this week in an effort to stem an expected tide of infections and hospitalizations this fall. But it’s unclear how much protection the new booster shots will provide. The Food and Drug Administration and the Centers for Disease Control and Prevention cleared the shots […]
Read More
CDC panel recommends new omicron Covid boosters with shots expected to begin next week
Justin Sullivan | Getty Images The Centers for Disease Control and Prevention’s independent committee on vaccines recommended reformulated booster shots that target the latest omicron subvariants. The panel voted 13 to 1 Thursday in favor of the shots after reviewing the available safety and effectiveness data in an almost seven-hour-long meeting. CDC Director Dr. Rochelle […]
Read More
U.S. health officials brace for another fall Covid surge, but with fewer deaths
People walk past a COVID-19 walk up testing site on July 28, 2022 in New York City. Liao Pan | China News Service | Getty Images Fall is on the horizon and public health officials are again bracing for another wave of Covid cases. Over the past two years, fall and winter have brought devastating […]
Read More
FDA authorizes Covid booster shots that target omicron BA.5 variant
A medical staff prepares a booster dose of Pfizer’s coronavirus disease (COVID-19) vaccine are seen at a vaccination centre in Brussels, Belgium, January 5, 2022. Yves Herman | Reuters The Food and Drug Administration authorized Covid booster shots that target the omicron BA.5 subvariant as the U.S. prepares for another surge of infections this fall […]
Read More
Piper Sandler names Illumina a top pick, says genetics company can surge more than 50%
Shares of Illumina can surge more than 50% from here on the back of new product launches, according to Piper Sandler. Analyst David Westenberg named biotech company Illumina a top pick and reiterated his overweight rating on the stock, citing new sequencing products that could drive growth at the company. “We hosted Illumina on our […]
Read More